4.5 Article

P3HT-based organic field effect transistor for low-cost, label-free detection of immunoglobulin G

Journal

JOURNAL OF BIOTECHNOLOGY
Volume 359, Issue -, Pages 75-81

Publisher

ELSEVIER
DOI: 10.1016/j.jbiotec.2022.09.022

Keywords

Poly(3-hexylthiophene); Organic field effect transistor; Immunoglobulin G

Funding

  1. Science and Tech- nology Department of Shanxi Province - Applied Basic Research Programs of Science and Technology Department of Shanxi Province
  2. Scientific and Techno- logical Innovation Programs of Higher Education Institutions in Shanxi
  3. [20210302124197]
  4. [20210302123136]
  5. [2019L0235]
  6. [2021L535]

Ask authors/readers for more resources

This paper presents a simple and inexpensive method for label-free detection of IgG using an active dielectric bilayer field effect transistor, showing high selectivity and broad commercialization prospects.
Currently, organic field effect transistors (OFETs) are widely used in the field of biodetection because of their inherent gain amplification function and good biocompatibility. However, the vast majority of OFET biosensors have disadvantages including a long preparation cycle, complicated processing and expensive materials. Thus, this paper proposes a simple and inexpensive preparation method for label-free detection of immunoglobulin G (IgG). In this work an active dielectric bilayer field effect transistor with 3D-printed silver source and drain electrodes was used. The active layer was modified by physically adsorbing an anti-IgG antibody on P3HT as a recognition element and then sealed with bovine serum albumin (BSA) to prevent nonspecific adsorption. The carrier mobility of the bilayer dielectric layer active field effect transistor reached 4.6 x 10-2 cm2/Vs, and the dynamic detection range for IgG spanned 6 orders of magnitude with a detection limit of 2.9 Picomolar (pM). Controlled experiments demonstrated that the developed sensor has high selectivity for IgG. Overall, this easy-to -operate and low-cost OFET biosensor has broad commercialization prospects and lays the foundation for the early clinical detection of disease-causing biomolecules.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available